US2016184427A1PendingUtilityA1

Quil a fraction with low toxicity and use thereof

Assignee: Novavax ABPriority: Jul 7, 2003Filed: Feb 26, 2016Published: Jun 30, 2016
Est. expiryJul 7, 2023(expired)· nominal 20-yr term from priority
A61K 2039/55577A61K 2039/57A61K 39/39
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Fraction A of Quil A can be used together with at least one other adjuvant for the preparation of an adjuvant composition, where the included adjuvant components act synergistically to enhance level of immune response and have synergistic immunomodulating activity on the co-administered antigens or immunogens. Other adjuvants can comprise saponins, naturally occurring, synthetic or semisynthetic saponin molecules; e.g. saponins and saponin fractions from Quil A, cell wall skeleton, block polymers, TDM, lipopeptides, LPS and LPS-derivatives, Lipid A from different bacterial species and derivatives thereof, e.g., monophosphoryl lipid A, CpG variants, CT and LT or fractions thereof.

Claims

exact text as granted — not AI-modified
1 . Use of fraction A of Quil A together with at least one other adjuvant for the preparation of an adjuvant composition with synergistic effect including enhancement of immune responses and immunomodulating activity.

Join the waitlist — get patent alerts

Track US2016184427A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.